Track ARMP and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
ARMP - Armata Pharmaceuticals Inc (ARMP) has a free cash flow of -$26.30M, up 33.3% over the past year and down 4.3% per year over the past five years.
FCF TTM
-$26.30M
FCF Margin
-536.40%
FCF Yield
-13.85%
5Y CAGR
-4.31%
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$26.30M | +33.29% |
| 2024 | -$39.43M | +30.19% |
| 2023 | -$56.48M | -62.82% |
| 2022 | -$34.69M | -39.44% |
| 2021 | -$24.88M | -30.30% |
| 2020 | -$19.09M | -20.80% |
| 2019 | -$15.81M | -67.69% |
| 2018 | -$9.43M | -1.90% |
| 2017 | -$9.25M | +14.89% |
| 2016 | -$10.87M | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q4 2025 | -$6.73M | -48.15% |
| Q3 2025 | -$4.54M | +38.32% |
| Q2 2025 | -$7.36M | +4.15% |
| Q1 2025 | -$7.68M | +2.18% |
| Q4 2024 | -$7.85M | +14.70% |
| Q3 2024 | -$9.20M | +20.27% |
| Q2 2024 | -$11.54M | -6.54% |
| Q1 2024 | -$10.83M | -3.12% |
| Q4 2023 | -$10.51M | +20.40% |
| Q3 2023 | -$13.20M | +0.00% |
| Q2 2023 | -$13.20M | +32.59% |
| Q1 2023 | -$19.58M | -95.21% |
| Q4 2022 | -$10.03M | +13.74% |
| Q3 2022 | -$11.63M | -25.24% |
| Q2 2022 | -$9.28M | -147.51% |
| Q1 2022 | -$3.75M | +57.50% |
| Q4 2021 | -$8.83M | -59.14% |
| Q3 2021 | -$5.55M | -17.15% |
| Q2 2021 | -$4.73M | +18.00% |
| Q1 2021 | -$5.77M | +13.42% |
| Q4 2020 | -$6.67M | -68.34% |
| Q3 2020 | -$3.96M | +4.07% |
| Q2 2020 | -$4.13M | +4.77% |
| Q1 2020 | -$4.34M | -57.67% |
| Q4 2019 | -$2.75M | +38.92% |
| Q3 2019 | -$4.50M | +24.04% |
| Q2 2019 | -$5.93M | -125.62% |
| Q1 2019 | -$2.63M | -8.06% |
| Q4 2018 | -$2.43M | -93.71% |
| Q3 2018 | -$1.25M | +43.06% |
| Q2 2018 | -$2.20M | +37.67% |
| Q1 2018 | -$3.54M | -48.14% |
| Q4 2017 | -$2.39M | -281.31% |
| Q3 2017 | -$626.00K | +78.66% |
| Q2 2017 | -$2.93M | +11.23% |
| Q1 2017 | -$3.30M | -121.15% |
| Q4 2016 | -$1.49M | +52.72% |
| Q3 2016 | -$3.16M | -4.74% |
| Q2 2016 | -$3.02M | +5.63% |
| Q1 2016 | -$3.20M | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.